165 related articles for article (PubMed ID: 18053706)
1. Xeroderma pigmentosum complementation group C genotypes/diplotypes play no independent or interaction role with polycyclic aromatic hydrocarbons-DNA adducts for breast cancer risk.
Shen J; Gammon MD; Terry MB; Teitelbaum SL; Eng SM; Neugut AI; Santella RM
Eur J Cancer; 2008 Mar; 44(5):710-7. PubMed ID: 18053706
[TBL] [Abstract][Full Text] [Related]
2. Polymorphisms in nucleotide excision repair genes, polycyclic aromatic hydrocarbon-DNA adducts, and breast cancer risk.
Crew KD; Gammon MD; Terry MB; Zhang FF; Zablotska LB; Agrawal M; Shen J; Long CM; Eng SM; Sagiv SK; Teitelbaum SL; Neugut AI; Santella RM
Cancer Epidemiol Biomarkers Prev; 2007 Oct; 16(10):2033-41. PubMed ID: 17932351
[TBL] [Abstract][Full Text] [Related]
3. Polymorphism in the DNA repair gene XPD, polycyclic aromatic hydrocarbon-DNA adducts, cigarette smoking, and breast cancer risk.
Terry MB; Gammon MD; Zhang FF; Eng SM; Sagiv SK; Paykin AB; Wang Q; Hayes S; Teitelbaum SL; Neugut AI; Santella RM
Cancer Epidemiol Biomarkers Prev; 2004 Dec; 13(12):2053-8. PubMed ID: 15598760
[TBL] [Abstract][Full Text] [Related]
4. Polymorphisms in XRCC1 modify the association between polycyclic aromatic hydrocarbon-DNA adducts, cigarette smoking, dietary antioxidants, and breast cancer risk.
Shen J; Gammon MD; Terry MB; Wang L; Wang Q; Zhang F; Teitelbaum SL; Eng SM; Sagiv SK; Gaudet MM; Neugut AI; Santella RM
Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):336-42. PubMed ID: 15734955
[TBL] [Abstract][Full Text] [Related]
5. IGHMBP2 Thr671Ala polymorphism might be a modifier for the effects of cigarette smoking and PAH-DNA adducts to breast cancer risk.
Shen J; Terry MB; Gammon MD; Gaudet MM; Teitelbaum SL; Eng SM; Sagiv SK; Neugut AI; Santella RM
Breast Cancer Res Treat; 2006 Sep; 99(1):1-7. PubMed ID: 16752224
[TBL] [Abstract][Full Text] [Related]
6. Reduced nucleotide excision repair and GSTM1-null genotypes influence anti-B[a]PDE-DNA adduct levels in mononuclear white blood cells of highly PAH-exposed coke oven workers.
Pavanello S; Pulliero A; Siwinska E; Mielzynska D; Clonfero E
Carcinogenesis; 2005 Jan; 26(1):169-75. PubMed ID: 15471894
[TBL] [Abstract][Full Text] [Related]
7. PAH-DNA adducts, cigarette smoking, GST polymorphisms, and breast cancer risk.
McCarty KM; Santella RM; Steck SE; Cleveland RJ; Ahn J; Ambrosone CB; North K; Sagiv SK; Eng SM; Teitelbaum SL; Neugut AI; Gammon MD
Environ Health Perspect; 2009 Apr; 117(4):552-8. PubMed ID: 19440493
[TBL] [Abstract][Full Text] [Related]
8. Polymorphisms in the DNA repair enzyme XPD are associated with increased levels of PAH-DNA adducts in a case-control study of breast cancer.
Tang D; Cho S; Rundle A; Chen S; Phillips D; Zhou J; Hsu Y; Schnabel F; Estabrook A; Perera FP
Breast Cancer Res Treat; 2002 Sep; 75(2):159-66. PubMed ID: 12243508
[TBL] [Abstract][Full Text] [Related]
9. Reduced DNA repair of benzo[a]pyrene diol epoxide-induced adducts and common XPD polymorphisms in breast cancer patients.
Shi Q; Wang LE; Bondy ML; Brewster A; Singletary SE; Wei Q
Carcinogenesis; 2004 Sep; 25(9):1695-700. PubMed ID: 15090466
[TBL] [Abstract][Full Text] [Related]
10. The relationship between genetic damage from polycyclic aromatic hydrocarbons in breast tissue and breast cancer.
Rundle A; Tang D; Hibshoosh H; Estabrook A; Schnabel F; Cao W; Grumet S; Perera FP
Carcinogenesis; 2000 Jul; 21(7):1281-9. PubMed ID: 10874004
[TBL] [Abstract][Full Text] [Related]
11. Polycyclic aromatic hydrocarbon (PAH)-DNA adducts and breast cancer: modification by gene promoter methylation in a population-based study.
White AJ; Chen J; McCullough LE; Xu X; Cho YH; Teitelbaum SL; Neugut AI; Terry MB; Hibshoosh H; Santella RM; Gammon MD
Cancer Causes Control; 2015 Dec; 26(12):1791-802. PubMed ID: 26407953
[TBL] [Abstract][Full Text] [Related]
12. Genotypes, haplotypes and diplotypes of XPC and risk of bladder cancer.
Zhu Y; Lai M; Yang H; Lin J; Huang M; Grossman HB; Dinney CP; Wu X
Carcinogenesis; 2007 Mar; 28(3):698-703. PubMed ID: 17052994
[TBL] [Abstract][Full Text] [Related]
13. Association of XPC polymorphisms with susceptibility and clinical outcome to chemotherapy in breast cancer patients.
Yang X; Liu D; Wu H; Kang H; Pang H; Huang D; Sha X; Wang E; Wang Z; Wei M
Cancer Sci; 2012 Jul; 103(7):1207-14. PubMed ID: 22519360
[TBL] [Abstract][Full Text] [Related]
14. [Association of XPC gene polymorphisms with breast cancer risk].
Wu YY; Ma XY; Yao KY; Li QL; Chen K
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2011 May; 40(3):252-8. PubMed ID: 21671483
[TBL] [Abstract][Full Text] [Related]
15. [Correlation of XPC Ala499Val and Lys939Gln polymorphisms to risks of esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma].
Zhou RM; Li Y; Wang N; Zhang XJ; Dong XJ; Guo W
Ai Zheng; 2006 Sep; 25(9):1113-9. PubMed ID: 16965652
[TBL] [Abstract][Full Text] [Related]
16. Environmental toxins and breast cancer on Long Island. I. Polycyclic aromatic hydrocarbon DNA adducts.
Gammon MD; Santella RM; Neugut AI; Eng SM; Teitelbaum SL; Paykin A; Levin B; Terry MB; Young TL; Wang LW; Wang Q; Britton JA; Wolff MS; Stellman SD; Hatch M; Kabat GC; Senie R; Garbowski G; Maffeo C; Montalvan P; Berkowitz G; Kemeny M; Citron M; Schnabel F; Schuss A; Hajdu S; Vinceguerra V
Cancer Epidemiol Biomarkers Prev; 2002 Aug; 11(8):677-85. PubMed ID: 12163319
[TBL] [Abstract][Full Text] [Related]
17. Association of DNA repair gene XPC Ala499Val (rs2228000 C>T) and Lys939Gln (rs2228001 A>C) polymorphisms with the risk of chronic myeloid leukemia: A case-control study in a South Indian population.
Lakkireddy S; Aula S; Kapley A; Gundeti S; Kutala VK; Jamil K
J Gene Med; 2021 Jul; 23(7):e3339. PubMed ID: 33829606
[TBL] [Abstract][Full Text] [Related]
18. Influence of GSTM1 null and low repair XPC PAT+ on anti-B[a]PDE-DNA adduct in mononuclear white blood cells of subjects low exposed to PAHs through smoking and diet.
Pavanello S; Pulliero A; Clonfero E
Mutat Res; 2008 Feb; 638(1-2):195-204. PubMed ID: 18035379
[TBL] [Abstract][Full Text] [Related]
19. Xeroderma pigmentosum complementation group C single-nucleotide polymorphisms in the nucleotide excision repair pathway correlate with prolonged progression-free survival in advanced ovarian cancer.
Fleming ND; Agadjanian H; Nassanian H; Miller CW; Orsulic S; Karlan BY; Walsh CS
Cancer; 2012 Feb; 118(3):689-97. PubMed ID: 21751198
[TBL] [Abstract][Full Text] [Related]
20. Genetic variation of TP53, polycyclic aromatic hydrocarbon-related exposures, and breast cancer risk among women on Long Island, New York.
Gaudet MM; Gammon MD; Bensen JT; Sagiv SK; Shantakumar S; Teitelbaum SL; Eng SM; Neugut AI; Santella RM
Breast Cancer Res Treat; 2008 Mar; 108(1):93-9. PubMed ID: 17624591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
